H.O.P.E: Helping Ovarian Cancer Patients Cope
Status
Conditions
Treatments
Details and patient eligibility
About
The purpose of this study is to test the effect of the gynecologic oncologists with palliative care specialist collaboration (GO-PC) intervention on patient quality of life.
Full description
Eligible patients include women diagnosed with platinum-resistant ovarian cancer or recurrent ovarian cancer cancer. All patient participants will complete two quality of life (QOL) questionnaires and a cost-diary documenting their health care experience at time of consent and every 12 weeks thereafter. Consenting care givers will also be asked to complete two questionnaires to asses the impact of structured palliative care on them every 12 weeks.
Patients will be assigned to two arms randomly: 1) usual care or 2) structured palliative care. The primary endpoint is quality of life. A two-sided Chi-square test will be used to compare the proportion of patients who have improved quality of life after treatment between control arm and intervention arm. The average value of multiple scores after treatment will be used to compare with the baseline score before treatment for each question in the standard questionnaire.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Platinum-resistant ovarian cancer or recurrent ovarian cancer
- Ability to read and respond to questions in English
Exclusion criteria
- Platinum-sensitive recurrent ovarian cancer without a significant clinical event
- Existence of co-morbid disease, which in the opinion of the investigator prohibits participation in the protocol
Trial design
Primary purpose
Allocation
Interventional model
Masking
47 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal